Evidence map›Paper›PMID 33912068›Full record

ArticleFrontiers in physiology2021

Serum Creatinine as a Potential Biomarker of Skeletal Muscle Atrophy in Non-small Cell Lung Cancer Patients.

Willian das Neves, Christiano R R Alves, Ana Paula de Souza Borges, Gilberto de Castro

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Journal of microbiology and biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Wearable Bioelectronics for Home-Based Monitoring and Treatment of Muscle Atrophy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Willian das NevesInstituto do Cancer do Estado de São Paulo ICESP, Hospital das Clinicas HC FMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Christiano R R AlvesCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
Ana Paula de Souza BorgesInstituto do Cancer do Estado de São Paulo ICESP, Hospital das Clinicas HC FMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Gilberto de CastroInstituto do Cancer do Estado de São Paulo ICESP, Hospital das Clinicas HC FMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Instituto do Câncer do Estado de São Paulo · BRMassachusetts General Hospital · USUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer cachexiacreatinine metabolismmuscle atrophymuscle wastingsarcopenia

Identifiers

PMID33912068
PMCPMC8072336
OpenAlexW3156845507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.